Company Search:
Advanced Search
Sponsored Links
Grifols SA Company Snapshot
Grifols SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grifols SA with three other pharmaceutical manufacturers in Europe: Ipsen SA of FRANCE (2019 sales of 2.69 billion Euros [US$3.27 billion] of which 85% was Specialty Care), UCB Sa of BELGIUM (4.91 billion Euros [US$5.97 billion] of which 35% was Cimzia), and Lonza Group AG which is based in SWITZERLAND (5.92 billion Swiss Francs [US$6.67 billion] of which 70% was Pharma&Biotech).

Sales Analysis. Grifols SA reported sales of 5.10 billion Euro (US$6.20 billion) for the year ending December of 2019. This represents an increase of 13.6% versus 2018, when the company's sales were 4.49 billion Euro. Sales at Grifols SA have increased during each of the previous five years (and since 2014, sales have increased a total of 52%). Sales of Bio Supplies saw an increase that was more than double the company's growth rate: sales were up 59.6% in 2019, from 167.00 million Euro to 266.54 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grifols SA
  Stock Performance Chart for Grifols SA
  Stock Data: Recent Stock Performance:
  Current Price (1/8/2021): 23.82
(Figures in Euros )
1 Week -0.3%   13 Weeks -1.2%  
4 Weeks -6.3%   52 Weeks -27.4%  
Grifols SA Key Data:
  Ticker: GRF Country: Spain
  Exchanges: MAD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 5,098,691,000
(Year Ending Jan 2020).
Employees: 24,016
  Currency: Euros Market Cap: 16,296,103,918
  Fiscal Yr Ends: December Shares Outstanding: 684,135,345
  Share Type: ORDINARY Closely Held Shares: 145,690,603
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.